Launching in 2026, IJTLD Chronic Respiratory Disease (IJTLD CRD) is a new open access journal (fully compliant with Plan S).
The Journal will feature the latest research on chronic lung conditions in LMICs to improve access to knowledge and influence care, policy and practise for better health.
Each issue of IJTLD CRD will include a mix of articles, including: PTLD – Asthma – COPD – Impact of air pollution – Lung damage in smokers – Interstitial lung disease – Bronchiectasis – Long COVID – Sleep apnea – Occupational lung disease – Interventional pulmonology.
This critically neglected area accounts for an estimated 4 million annual deaths and affects 28–90 million people with PTLD.
We encourage authors working on chronic respiratory disease to submit their latest research on all aspects of the management and care of patients. We will consider Editorials, Meeting Reports, Original Research (including methodology papers and qualitative research), Reviews, Viewpoints, Study Protocols, Case Series, Case Reports and Letters.
We are particularly keen to promote research on early diagnosis and treatments – including the latest therapeutic advances that have relevance across a wide range of respiratory conditions. Our aim is to highlight the importance of these conditions to influence policymakers and improve clinical care in LMICs.
For all queries please e-mail the Editorial team at journal@theunion.org
While preparing their article, authors should refer to the Instructions for Authors to check that they have complied with our requirements – see links below.
Once complete, authors should submit their manuscripts at http://mc.manuscriptcentral.com/ijtld
Sponsorship
Supplements and article series are a highly-effective way of highlighting a specific topic to researchers, clinicians and decision makers in respiratory health.
Being an Open Access journal, IJTLD CRD has no barriers to access and can reach readers in health centres, medical, university and pharmaceutical institutes, along with civil society, patients and carers.
All content will be freely available and acknowledge the sponsors support and readers will receive emails to highlight sponsored content.
Fast-Track Articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD, IJTLD OPEN and PHA and publishing them in full on our website, prior to their publication in the Journals. Read fast-track articles:
Call to action for an invigorated drive to scale up TB prevention
An Editorial for IJTLD highlights the importance of TB preventive treatment (TPT) and the launch by WHO, governments, civil society and other partners of a ‘Call to Action’ for broader access to TPT for those in need. The article is free to read.
Impact of COVID-19 on TB detection in the private sector in Nepal
In this Correspondence accepted article for IJTLD, the authors found a 67.4% decrease in testing, a 66.9% decrease in bacteriologically confirmed (bac+) diagnosis and a 58.9% decrease in diagnosis of all forms TB. The preprint is free to read.
Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19
In this recently accepted article for IJTLD, the authors found that RR-TB diagnosis decreased by 21–38% following the start of the pandemic. The results are disturbing and suggest that COVID-19 has had a sustained impact at a time when household transmission of TB/RR-TB might have increased due to ‘shelter at home’. The preprint is free to read.